Minas Economides, MD (@minaseconomides) 's Twitter Profile
Minas Economides, MD

@minaseconomides

GU Medical Oncologist. Assistant Professor of Medicine @nyulangone @Perlmutter_CC. Associate Program Director @NYUGSOM_HemeOnc. Tweets are my own.

ID: 331064039

linkhttps://nyulangone.org/doctors/1831621960/minas-p-economides calendar_today07-07-2011 16:00:26

869 Tweet

720 Followers

989 Following

Sumanta K. Pal, MD, FASCO (@montypal) 's Twitter Profile Photo

Many thanks to Kidney Cancer for funding the #KidneyCancer Association Mentorship Academy. Brilliant time so far hosting the brilliant Minas Economides, MD from New York University at City of Hope. Busy day in clinic but managed to see most of our beautiful campus! Dan George

Many thanks to <a href="/KidneyCancer/">Kidney Cancer</a> for funding the #KidneyCancer Association Mentorship Academy. Brilliant time so far hosting the brilliant <a href="/minaseconomides/">Minas Economides, MD</a> from <a href="/nyuniversity/">New York University</a> at <a href="/cityofhope/">City of Hope</a>. Busy day in clinic but managed to see most of our beautiful campus! <a href="/Daniel_J_George/">Dan George</a>
Andrea Necchi (@andreanecchi) 's Twitter Profile Photo

What an incredible 2-day experience in LA. So thankful to Sumanta K. Pal, MD, FASCO &. Team for visiting City of Hope and learning from his visionary mentorship and initiatives ongoing. So inspired by the crowded Southern California GU Oncology network and brains, the future of patients is in the

What an incredible 2-day experience in LA. So thankful to <a href="/montypal/">Sumanta K. Pal, MD, FASCO</a> &amp;. Team for visiting <a href="/cityofhope/">City of Hope</a> and learning from his visionary mentorship and initiatives ongoing. So inspired by the crowded Southern California GU Oncology network and brains, the future of patients is in the
NYU Langone Health (@nyulangone) 's Twitter Profile Photo

We are thrilled to announce the appointment of Alec C. Kimmelman, MD, PhD, as the next Chief Executive Officer at NYU Langone Health and Dean of NYU Grossman School of Medicine effective September 1, 2025. Learn more: nyulangone.org/news/nyu-lango…

We are thrilled to announce the appointment of Alec C. Kimmelman, MD, PhD, as the next Chief Executive Officer at <a href="/nyulangone/">NYU Langone Health</a> and Dean of <a href="/nyugrossman/">NYU Grossman School of Medicine</a> effective September 1, 2025.

Learn more: nyulangone.org/news/nyu-lango…
OncLive.com (@onclive) 's Twitter Profile Photo

What’s shaping the future of #GenitourinaryCancers? Find out April 30 in NYC at the State of the Science Summit™ with David Wise MD PhD, David H Aggen, MD PhD, Mark Stein, & Minas Economides, MD. Don't miss it! Register today: hubs.li/Q03hKl0G0 NYU Langone Health

What’s shaping the future of #GenitourinaryCancers? Find out April 30 in NYC at the State of the Science Summit™ with <a href="/DrDaveWise/">David Wise MD PhD</a>, <a href="/Dr_Aggen/">David H Aggen, MD PhD</a>, <a href="/drmnstein/">Mark Stein</a>, &amp; <a href="/minaseconomides/">Minas Economides, MD</a>. Don't miss it!

Register today: hubs.li/Q03hKl0G0 <a href="/nyulangone/">NYU Langone Health</a>
Sumanta K. Pal, MD, FASCO (@montypal) 's Twitter Profile Photo

Finally had a chance to listen to the discussion EVERYONE in the GU community is talking about via ASCO Virtual Meeting. One of the most thoughtful & eloquent discussions I have ever seen by Jacqueline T. Brown, MD Winship Cancer Institute of Emory University, summarizing excellent presentations from Michiel van der Heijden

Finally had a chance to listen to the discussion EVERYONE in the GU community is talking about via <a href="/ASCO/">ASCO</a> Virtual Meeting. One of the most thoughtful &amp; eloquent discussions I have ever seen by <a href="/jackiebrown_MD/">Jacqueline T. Brown, MD</a> <a href="/WinshipAtEmory/">Winship Cancer Institute of Emory University</a>, summarizing excellent presentations from <a href="/MichvdHeijden/">Michiel van der Heijden</a>
UroToday.com (@urotoday) 's Twitter Profile Photo

Phase I trial combines ONC-392 with Lutetium-177 for #ProstateCancer. David Wise, MD, PhD NYU Langone Health joins Tian Zhang, MD, MHS UT Southwestern Medical Center discussing this phase I trial of ONC-392 + 177Lu-PSMA, targeting Tregs to overcome resistance after lutetium therapy. Early results: safe, no

Pavlos Msaouel (@pavlosmsaouel) 's Twitter Profile Photo

1/5 This comes up in #kidneycancer clinic every few months. And on patient groups just as often. 📊 The ASSURE nomogram shows cumulative disease-free survival (DFS) from time 0 after surgery. Great info… until someone hits the 2-year mark and panics at that 48.8% 3-year number.

1/5 This comes up in #kidneycancer clinic every few months. And on patient groups just as often.
📊 The ASSURE nomogram shows cumulative disease-free survival (DFS) from time 0 after surgery. Great info… until someone hits the 2-year mark and panics at that 48.8% 3-year number.
John P. Leonard, MD (@johnpleonardmd) 's Twitter Profile Photo

Sharing some personal news - excited for this next step! NYU Langone Names Chief of Division of Hematology & Medical Oncology & Director of the Center for Blood Cancers nyulangone.org/news/nyu-lango…

Mark D. Siegel (@markdsiegel1) 's Twitter Profile Photo

Program Director’s Note - Personal Statement Pitfalls A #ProgramDirectorsNote to my Yale IM Traditional Residency Program residents now that fellowship applications are in. My Yale Internal Medicine are great writers, but there are always pitfalls to avoid. open.substack.com/pub/siegelmark…

Program Director’s Note - Personal Statement Pitfalls 

A #ProgramDirectorsNote to my <a href="/TradIMYale/">Yale IM Traditional Residency Program</a> residents now that fellowship applications are in. My <a href="/YaleIMed/">Yale Internal Medicine</a> are great writers, but there are always pitfalls to avoid. 

open.substack.com/pub/siegelmark…